Viridian Therapeutics Stock Options
| VRDN Stock | USD 21.00 0.55 2.55% |
Viridian Therapeutics' latest option contracts expiring on 2024-12-20 are carrying combined implied volatility of 0.14 with a put-to-call open interest ratio of 0.0 over 8 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2024-12-20. The total put volume is at 106, with calls trading at the volume of 106. This yields a 1.12 put-to-call volume ratio.
Viridian Therapeutics' option chain provides insight into all available option contracts written on Viridian Therapeutics' stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of Viridian Therapeutics' stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given Viridian option contract.
In The Money vs. Out of Money Option Contracts on Viridian Therapeutics
Analyzing Viridian Therapeutics' in-the-money options over time can help investors to take a profitable long position in Viridian Therapeutics regardless of its overall volatility. This is especially true when Viridian Therapeutics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Viridian Therapeutics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Viridian Therapeutics' stock while costing only a fraction of its price.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Viridian Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
Please note that buying 'in-the-money' options on Viridian Therapeutics lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Viridian Therapeutics' value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Viridian Therapeutics contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Viridian Stock moves the wrong way.
Viridian Therapeutics In The Money Call Balance
When Viridian Therapeutics' strike price is surpassing the current stock price, the option contract against Viridian Therapeutics stock is said to be in the money. When it comes to buying Viridian Therapeutics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Viridian Therapeutics are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Viridian Current Options Market Mood
Viridian Therapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Viridian Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Volume
Unfortunately, most Viridian Therapeutics' options investors are not very successful. Viridian Therapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Viridian contract
Base on the Rule 16, the options market is currently suggesting that Viridian Therapeutics will have an average daily up or down price movement of about 0.00875% per day over the life of the 2024-12-20 option contract. With Viridian Therapeutics trading at USD 21.0, that is roughly USD 0.001838. If you think that the market is fully incorporating Viridian Therapeutics' daily price movement you should consider buying Viridian Therapeutics options at the current volatility level of 0.14%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Viridian |
Purchasing Viridian Therapeutics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Viridian calls. Remember, the seller must deliver Viridian Therapeutics stock to the call owner when a call is exercised.
Viridian Therapeutics Option Chain
When Viridian Therapeutics' strike price is surpassing the current stock price, the option contract against Viridian Therapeutics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Viridian Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on Viridian. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Viridian. It also shows strike prices and maturity days for a Viridian Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Expiration | Current Spread | Last Price | |||
Call | VRDN Option Call 20-12-2024 17 | 0 | 2024-12-20 | 0.0 - 0.0 | 3.0 | In |
Call | VRDN Option Call 20-12-2024 20 | 0 | 2024-12-20 | 0.0 - 0.0 | 2.55 | In |
Call | VRDN Option Call 20-12-2024 22 | 0 | 2024-12-20 | 0.0 - 0.0 | 1.45 | |
Call | VRDN Option Call 20-12-2024 25 | 0 | 2024-12-20 | 0.0 - 0.0 | 0.3 | |
Call | VRDN Option Call 20-12-2024 30 | 0 | 2024-12-20 | 0.0 - 0.0 | 0.05 | |
Put | VRDN Option Put 20-12-2024 17 | 0 | 2024-12-20 | 0.0 - 0.0 | 0.45 | |
Put | VRDN Option Put 20-12-2024 20 | 0 | 2024-12-20 | 0.0 - 0.0 | 1.15 | |
Put | VRDN Option Put 20-12-2024 22 | 0 | 2024-12-20 | 0.0 - 0.0 | 2.0 | In |
Viridian Therapeutics Selling And Marketing Expenses Over Time
Selling And Marketing Expenses |
| Timeline |
Viridian Therapeutics Market Cap Over Time
Market Cap |
| Timeline |
Viridian Total Stockholder Equity
Total Stockholder Equity |
|
Viridian Therapeutics Corporate Management
| Seth Harmon | Principal Accounting | Profile | |
| Anthony Casicano | Chief Officer | Profile | |
| Kristian MBA | Chief CFO | Profile | |
| Melissa Manno | Chief Officer | Profile | |
| Anthony Casciano | Chief Officer | Profile | |
| Jennifer JD | Chief Officer | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Viridian Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. To learn how to invest in Viridian Stock, please use our How to Invest in Viridian Therapeutics guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Viridian Therapeutics. If investors know Viridian will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Viridian Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.32) | Revenue Per Share 0.005 | Quarterly Revenue Growth 0.194 | Return On Assets (0.32) | Return On Equity (0.52) |
The market value of Viridian Therapeutics is measured differently than its book value, which is the value of Viridian that is recorded on the company's balance sheet. Investors also form their own opinion of Viridian Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Viridian Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Viridian Therapeutics' market value can be influenced by many factors that don't directly affect Viridian Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Viridian Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Viridian Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Viridian Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.